Novel Insights into the Immunomodulatory Effects of Caryophyllane Sesquiterpenes: A Systematic Review of Preclinical Studies
Source abstract
Abstract
Immunomodulation is a key factor in the homeostasis of organisms, both for physiological and inflammatory conditions. In this context, great attention has been devoted to immunomodulant agents, which can boost or modulate the immune system, thus favoring disease relief. The present systematic review is focused on the immunomodulatory properties of plant-based caryophyllane sesquiterpenes, which are unique natural compounds widely studied due to their multiple and pleiotropic bioactivities. Despite lacking clinical evidence, the selected studies highlighted the ability of these substances, especially β-caryophyllene and α-humulene, to modulate the immune system of both in vitro and in vivo models of disease, such as neurodegenerative and inflammatory-based diseases, cancer, and allergies; moreover, some mechanistic hypotheses have been made too. The present overview suggests a further interest in immunomodulation by caryophyllane sesquiterpenes as a possible novel strategy for immune-based diseases or as an adjuvant treatment and encourages further high-quality studies, using high-purity compounds, to better clarify the mechanisms accounting for these properties and to support a further pharmaceutical development.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Phytochemistry and Biological Activities · Plant-derived Lignans Synthesis and Bioactivity · Natural Compounds in Disease Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Physiology and Pharmacology “V. Erspamer”, Sapienza University, Piazzale Aldo Moro 5, 00185 Rome, Italy
References (69)
Show source-provided references
1. Di Sotto, A., Mancinelli, R., Gullì, M., Eufemi, M., Mammola, C.L., Mazzanti, G., and Di Giacomo, S. (2020). Chemopreventive potential of caryophyllane sesquiterpenes: An overview of preliminary evidence. Cancers, 12.10.3390/cancers12103034 ↗
2. Di Giacomo, S., Mariano, A., Gullì, M., Fraschetti, C., Vitalone, A., Filippi, A., Mannina, L., Scotto d’Abusco, A., and Di Sotto, A. (2021). Role of caryophyllane sesquiterpenes in the entourage Effect of Felina 32 Hemp inflorescence Phytocomplex in triple negative MDA-MB-468 breast cancer cells. Molecules, 26.10.3390/molecules26216688 ↗
3. Multidisciplinary approach to determine the optimal time and period for extracting the essential oil from Mentha suaveolens Ehrh10.3390/molecules20069640 ↗
4. Schepetkin, I.A., Özek, G., Özek, T., Kirpotina, L.N., Khlebnikov, A.I., and Quinn, M.T. (2020). Chemical composition and immunomodulatory activity of Hypericum perforatum essential oils. Biomolecules, 10.10.3390/biom10060916 ↗
5. Ingallina, C., Sobolev, A.P., Circi, S., Spano, M., Fraschetti, C., Filippi, A., Di Sotto, A., Di Giacomo, S., Mazzoccanti, G., and Gasparrini, F. (2020). Cannabis sativa L. Inflorescences from Monoecious Cultivars Grown in Central Italy: An Untargeted Chemical Characterization from Early Flowering to Ripening. Molecules, 25.10.3390/molecules25081908 ↗
6. Mariano, A., Di Sotto, A., Leopizzi, M., Garzoli, S., Di Maio, V., Gullì, M., Dalla Vedova, P., Ammendola, S., and Scotto d’Abusco, A. (2020). Antiarthritic effects of a root extract from Harpagophytum procumbens DC: Novel insights into the molecular mechanisms and possible bioactive phytochemicals. Nutrients, 12.10.3390/nu12092545 ↗
7. Di Sotto, A., Vitalone, A., and Di Giacomo, S. (2020). Plant-Derived Nutraceuticals and Immune System Modulation: An Evidence-Based Overview. Vaccines, 8.10.3390/vaccines8030468 ↗
8. Structure and function of red and white blood cells and platelets10.1016/j.mpmed.2021.01.001 ↗
9. Drivers and regulators of humoral innate immune responses to infection and cancer10.1016/j.molimm.2020.03.005 ↗
10. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression10.1038/nature05115 ↗
11. Induction of regulatory cells by helminth parasites: Exploitation for the treatment of inflammatory diseases10.1111/imr.12164 ↗
12. B-lymphocyte contributions to human autoimmune disease10.1111/j.1600-065X.2008.00646.x ↗
13. Autoinflammatory disorders: A review and update on pathogenesis and treatment10.1007/s40257-019-00440-y ↗
14. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia10.1182/blood-2007-11-121723 ↗
15. Increased resistin may suppress reactive oxygen species production and inflammasome activation in type 2 diabetic patients with pulmonary tuberculosis infection10.1016/j.micinf.2014.11.009 ↗
16. High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation10.1016/j.febslet.2013.05.053 ↗
17. Filarial infection or antigen administration improves glucose tolerance in diet-induced obese mice10.1159/000448401 ↗
18. Macrophage-mediated inflammation in metabolic disease10.1038/nri3071 ↗
19. Restrepo, B.I., Twahirwa, M., Rahbar, M.H., and Schlesinger, L.S. (2014). Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia. PLoS ONE, 9.10.1371/journal.pone.0092977 ↗
20. Stress-induced microglia activation and monocyte trafficking to the brain underlie the development of anxiety and depression10.1007/7854_2016_25 ↗
21. Microglia across the lifespan: From origin to function in brain development, plasticity and cognition10.1113/JP272134 ↗
22. Effector/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity10.4049/jimmunol.0803829 ↗
23. The hallmarks of successful anticancer immunotherapy10.1126/scitranslmed.aat7807 ↗
24. Cancer immunotherapy: Challenges and limitations10.1016/j.prp.2021.153723 ↗
25. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): Explanation and elaboration10.1186/s12939-015-0219-2 ↗
26. Regulation of pain by neuro-immune interactions between macrophages and nociceptor sensory neurons10.1016/j.conb.2019.11.006 ↗
27. Protective and pathogenic functions of macrophage subsets10.1038/nri3073 ↗
28. Domoto, R., Sekiguchi, F., Tsubota, M., and Kawabata, A. (2021). Macrophage as a peripheral pain regulator. Cells, 10.10.3390/cells10081881 ↗
29. Macrophage polarization and meta- inflammation10.1016/j.trsl.2017.10.004 ↗
30. Metaxalone suppresses production of inflammatory cytokines associated with painful conditions in mouse macrophages RAW264.7 cells in Vitro: Synergistic effect with β-caryophyllene10.2174/1566524020666200217102508 ↗
31. The combination of catechin, baicalin and β-caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro
32. Da Silva, S.M.M., Costa, C.R.R., Gelfuso, G.M., Guerra, E.N.S., de Medeiros Nóbrega, Y.K., Gomes, S.M., Pic-Taylor, A., Fonseca-Bazzo, Y.M., Silveira, D., and Magalhães, P.O. (2018). Wound healing effect of essential oil extracted from Eugenia dysenterica DC (Myrtaceae) Leaves. Molecules, 24.10.3390/molecules24010002 ↗
33. Anti-inflammatory effects of 27 selected terpenoid compounds tested through modulating Th1/Th2 cytokine secretion profiles using murine primary splenocytes10.1016/j.foodchem.2013.04.044 ↗
34. Developmental and functional heterogeneity of monocytes10.1016/j.immuni.2018.10.005 ↗
35. β-Caryophyllene potently inhibits solid tumor growth and lymph node metastasis of B16F10 melanoma cells in high-fat diet–induced obese C57BL/6N mice10.1093/carcin/bgv076 ↗
36. Inhibitory effect of trans-caryophyllene (TC) on leukocyte- endothelial attachment10.1016/j.taap.2017.06.016 ↗
37. β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner10.1016/j.freeradbiomed.2012.01.014 ↗
38. β- Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway10.1016/j.ajpath.2010.11.052 ↗
39. β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease10.1007/s11010-016-2733-y ↗
40. The protective effects of β-caryophyllene on LPS-induced primary microglia M1/M2 imbalance: Mechanistic evaluation10.1016/j.lfs.2018.12.059 ↗
41. β-Caryophyllene protects against ischemic stroke by promoting polarization of microglia toward M2 phenotype via the TLR4 pathway10.1016/j.lfs.2019.116915 ↗
42. Trans-caryophyllene inhibits amyloid β (Aβ) oligomer-induced neuroinflammation in BV-2 microglial cells10.1016/j.intimp.2017.07.009 ↗
43. Beta-caryophyllene is a dietary cannabinoid10.1073/pnas.0803601105 ↗
44. Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE)10.1016/j.intimp.2019.105923 ↗
45. Alberti, T.B., Barbosa, W.L.R., Vieira, J.L.F., Raposo, N.R.B., and Dutra, R.C. (2017). (−)-β-Caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis. Int. J. Mol. Sci., 18.10.3390/ijms18040691 ↗
46. Inhibition by β-caryophyllene of ethyl methanesulfonate-induced clastogenicity in cultured human lymphocytes10.1016/j.mrgentox.2010.04.008 ↗
47. Genotoxicity assessment of β-caryophyllene oxide10.1016/j.yrtph.2013.04.006 ↗
48. Preventive and therapeutic anti-inflammatory properties of the sesquiterpene α-humulene in experimental airways allergic inflammation10.1111/j.1476-5381.2009.00177.x ↗
49. The role of sphingosine-1-phosphate and ceramide-1-phosphate in inflammation and cancer10.1155/2017/4806541 ↗
50. CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?10.1124/mol.114.094649 ↗
51. β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice10.1111/bph.13722 ↗
52. Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in rotenone model of Parkinson’s disease10.3389/fnins.2016.00321 ↗
53. Effect of two active compounds obtained from the essential oil of Cordia verbenacea on the acute inflammatory responses elicited by LPS in the rat paw10.1038/sj.bjp.0707270 ↗
54. Nonclassical patrolling monocyte function in the vasculature10.1161/ATVBAHA.114.304650 ↗
55. 1. Lymphocytes10.1016/j.jaci.2007.06.016 ↗
56. T helper cells plasticity in inflammation10.1002/cyto.a.22348 ↗
57. Chemotherapeutic potential of the volatile oils from Zanthoxylum rhoifolium Lam leaves10.1016/j.ejphar.2007.07.065 ↗
58. Functions of natural killer cells10.1038/ni1582 ↗
59. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-γ production10.4049/jimmunol.175.3.1636 ↗
60. Ready for prime time: NK cell priming by dendritic cells10.1016/j.immuni.2007.04.001 ↗
61. Elie Metchnikoff: Father of natural immunity10.1002/eji.200838855 ↗
62. Immunology’s foundation: The 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff10.1038/ni0708-705 ↗
63. Neutrophil granules: A library of innate immunity proteins10.1016/j.it.2007.06.002 ↗
64. Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: A new link between leukocytes upstream of T lymphocytes10.1189/jlb.0905526 ↗
65. Inflammatory pathways in alcoholic steatohepatitis10.1016/j.jhep.2018.10.023 ↗
66. A practical guide for transparent reporting of research on natural products in British Journal of Pharmacology: Reproducibility of natural product research10.1111/bph.15054 ↗
67. Di Sotto, A., Paolicelli, P., Nardoni, M., Abete, L., Božović, M., Di Giacomo, S., Mazzanti, G., Casadei, M.A., and Petralito, S. (2018). SPC Liposomes as possible delivery systems for improving bioavailability of the natural sesquiterpene β-caryophyllene: Lamellarity and drug-loading as key features for a rational drug delivery design. Pharmaceutics, 10.10.3390/pharmaceutics10040274 ↗
68. β-caryophyllene/hydroxypropyl-β-cyclodextrin inclusion complex improves cognitive deficits in rats with vascular dementia through the cannabinoid receptor type 2 -mediated pathway10.3389/fphar.2017.00002 ↗
69. Microemulsions containing Copaifera multijuga Hayne oil-resin: Challenges to achieve an efficient system for β-caryophyllene delivery10.1016/j.indcrop.2017.10.025 ↗